Lifecare (LIFE), a clinical-stage medical sensor company, has disclosed that its purchase order for a cleanroom has arrived in Germany following a delay.
The announcement came through a stock exchange announcement that is following the creation of a site for LIFE to develop its next-generation Continuous Glucose Monitor (CGM)
The update follows the Norway-based company’s announcement that it placed a purchase order for this cleanroom in March.
LIFE had to reschedule the installation of the cleanroom to late July and early August
The shipment of the cleanroom was delayed to Hamburg due to disturbances to the sea trade routes through the Middle East and Africa.
Consequently, LIFE had to reschedule the installation of the cleanroom to late July and early August.
The Norway-based company is now aiming to launch the Pilot Production Site within the new timeframe of Q3 2024.
The importance of cleanroom
Cleanrooms are always required where the airborne particles will likely contaminate the final product.
The sensor components consist of micro and nano technologies sensitive to particles
Lifecare’s cleanroom holds an ISO Class 7 standard, which will ensure that the airborne particles are maintained at a very low concentration to not interfere with crucial functions of sensor components during sensor manufacturing.
The sensor components for the CGM consist of micro and nano technologies sensitive to particles. The airborne particles could potentially impact the functionality of the sensor by blocking the nanofiltration layers and subsequent flow of the substances in and out of sensor cavities.
